SUN Pharmaceutical Industries Limited — Herbal Exporter Profile
Indian Pharmaceutical Exporter · #1 for Herbal · $3.1M export value · DGFT Verified
SUN Pharmaceutical Industries Limited is the #1 Indian exporter of Herbal with $3.1M in export value and 63 verified shipments. SUN Pharmaceutical Industries Limited holds a 16.7% market share in Herbal exports across 4 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.
SUN Pharmaceutical Industries Limited — Herbal Export Profile: Buyers & Destinations
Where Does SUN Pharmaceutical Industries Limited Export Herbal?
| Country | Value | Shipments | Share |
|---|---|---|---|
| RUSSIA | $3.6M | 78 | 75.8% |
| LITHUANIA | $525.8K | 29 | 11.1% |
| KAZAKISTAN | $275.8K | 13 | 5.8% |
| BELGIUM | $197.0K | 8 | 4.2% |
| KAZAKHSTAN | $100.0K | 2 | 2.1% |
| UKRAINE | $42.4K | 4 | 0.9% |
SUN Pharmaceutical Industries Limited exports Herbal to 6 countries. The largest destination is RUSSIA accounting for 75.8% of SUN Pharmaceutical Industries Limited's Herbal shipments, followed by LITHUANIA (11.1%) and KAZAKISTAN (5.8%). These destinations reflect SUN Pharmaceutical Industries Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Herbal from SUN Pharmaceutical Industries Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| AO "RANBAXY" | RUSSIA | $2.9M | 62 |
| AO RANBAXY | RUSSIA | $641.6K | 16 |
| UAB VILNIAUS TRANZITAS, | LITHUANIA | $232.3K | 13 |
| M S UAB VILNIAUS TRANZITAS JDOBKEVICIAUS STR | LITHUANIA | $169.8K | 8 |
| YUSEN LOGISTICS BENELUX BELGIUM | BELGIUM | $150.1K | 5 |
| M/S. FREE LINE DISTRIBTUION LLP. | KAZAKISTAN | $144.3K | 8 |
| LLP CBX ALATAU | KAZAKHSTAN | $100.0K | 2 |
| M S LLP CBX ALATAU | KAZAKISTAN | $100.0K | 2 |
| UAB VILNIAUS TRANZITAS | LITHUANIA | $78.2K | 4 |
| YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN | BELGIUM | $47.0K | 3 |
SUN Pharmaceutical Industries Limited supplies Herbal to 13 buyers globally. The largest buyer is AO "RANBAXY" (RUSSIA), followed by AO RANBAXY (RUSSIA) and UAB VILNIAUS TRANZITAS, (LITHUANIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Herbal Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?
India exported $10.7M worth of Herbal through 15,000 shipments from 320 suppliers to 115 countries, serving 500 buyers globally. SUN Pharmaceutical Industries Limited contributes $3.1M to this total, accounting for 16.7% of India's Herbal exports. SUN Pharmaceutical Industries Limited ships Herbal to 6 countries through 13 buyers.
What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Herbal Exports?
SUN Pharmaceutical Industries Limited's average Herbal shipment value is $50.0K per consignment, based on 63 shipments totaling $3.1M. The largest destination is RUSSIA (75.8% of SUN Pharmaceutical Industries Limited's Herbal exports).
How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Herbal Exporters?
SUN Pharmaceutical Industries Limited ranks #1 among 320 Indian Herbal exporters with a 16.7% market share. The top 3 exporters are SUN PHARMACEUTICAL INDUSTRIES LIMITED ($3.1M), EMAMI LIMITED ($1.2M), SURYA HERBAL LIMITED ($1.2M). SUN Pharmaceutical Industries Limited processed 63 shipments to 4 destination countries.
What Herbal Formulations Does SUN Pharmaceutical Industries Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| NEOTRAVISIL HERBAL LOZENGES HONEY-LEMON | $518.8K | 13 |
| NEOTRAVISIL HERBAL LOZENGES MINT NEOTRAV | $475.7K | 11 |
| NEOTRAVISIL HERBAL LOZENGES LEMON PACK: | $360.4K | 8 |
| NEOTRAVISIL HERBAL LOZENGES ORANGE PACK | $241.3K | 6 |
| NEOTRAVISIL HERBAL LOZENGES STRAWBERRY | $168.8K | 4 |
| Neotravisil Herbal Lozenges Honey-Lemon | $117.6K | 3 |
| Neotravisil Herbal Lozenges Mint Neotrav | $114.1K | 3 |
| NEOTRAVISIL HERBAL LOZENGES LEMON PACK | $100.0K | 2 |
| Neotravisil Herbal Lozenges Strawberry | $100.0K | 2 |
| Neotravisil Herbal Lozenges Lemon PACK | $100.0K | 2 |
SUN Pharmaceutical Industries Limited exports 66 distinct Herbal formulations including tablets, capsules, syrups, and combination drugs. The top formulation is NEOTRAVISIL HERBAL LOZENGES HONEY-LEMON with 13 shipments worth $518.8K.
How Does SUN Pharmaceutical Industries Limited Compare to Nearest Herbal Exporters?
Exporters ranked immediately above and below #1 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED ★ | $3.1M | 63 | 4 | $50.0K |
| 2 | EMAMI LIMITED | $1.2M | 78 | 10 | $15.6K |
| 3 | SURYA HERBAL LIMITED | $1.2M | 62 | 5 | $19.0K |
SUN Pharmaceutical Industries Limited ranks #1 among 320 Indian Herbal exporters. Average shipment value of $50.0K compared to the market average of $33.3K. The closest competitors by value are EMAMI LIMITED and SURYA HERBAL LIMITED.
Which Indian Ports Ship Herbal Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 10,888 | 72.6% |
| NHAVA SHEVA SEA (INNSA1) | 939 | 6.3% |
| TUGLAKABAD ICD (INTKD6) | 816 | 5.4% |
| PATPARGANJ ICD (INPPG6) | 383 | 2.6% |
| DADRI ICD (INDER6) | 367 | 2.4% |
| SAHAR AIR CARGO ACC (INBOM4) | 365 | 2.4% |
| TUTICORIN SEA (INTUT1) | 226 | 1.5% |
| CHENNAI SEA (INMAA1) | 190 | 1.3% |
Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Herbal Exports
Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)
In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)
The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)
SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)
Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.
About SUN Pharmaceutical Industries Limited
SUN Pharmaceutical Industries Limited exports 118 products worth $979.8M. Beyond Herbal, top products include Strip, Esomeprazole, Magnesium, Calcium, Omeprazole. View the complete SUN Pharmaceutical Industries Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Herbal — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Herbal shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 134 individual customs records matching SUN Pharmaceutical Industries Limited exporting Herbal, covering 66 formulations to 6 countries via 13 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 115+ countries, 500+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Herbal Export Data from SUN Pharmaceutical Industries Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for SUN Pharmaceutical Industries Limited's Herbal exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
SUN Pharmaceutical Industries Limited
Full Company Profile →
118 products · $979.8M total trade · 25 categories
Herbal Stats
Company Overview
Top Products by SUN Pharmaceutical Industries Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for SUN Pharmaceutical Industries Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Herbal. For current shipment-level data, contact TransData Nexus.